Roche Diagnostic Systems 07251254190 - Immunoassay Reagent cobas® Tacrolimus CLIA Non-Waived For cobas e Immunoassay Analyzers 300 Tests - 1/Pack
- Immunoassay for the in vitro quantitative determination of tacrolimus in EDTA human whole blood
- The assay is used as an aid in the management of liver and kidney transplant patients receiving tacrolimus therapy
- The electrochemiluminescence immunoassay ECLIA is intended for use on cobas e immunoassay analyzers
This product can be found in our Diagnostics -> Clinical Laboratory -> Laboratory Equipment -> Clinical Analyzers and Accessories -> Reagents section.
- SKU
- 100-1264573PC
Description / Roche Diagnostic Systems 07251254190 - Immunoassay Reagent cobas® Tacrolimus CLIA Non-Waived For cobas e Immunoassay Analyzers 300 Tests - 1/Pack
The Roche cobas Tacrolimus reagent is an immunoassay reagent, a laboratory reagent used on analyzers to run tests. It is made for cobas e Immunoassay Analyzers and is classified CLIA non-waived. Each pack provides 300 tests.
- Immunoassay reagent from the cobas series, made by Roche Diagnostic Systems
- CLIA non-waived
- For use with cobas e Immunoassay Analyzers
- 300 tests per pack
- Sample type: whole blood sample
- Container type: pack
- Volume: M: 12.4 mL, R1: 21 mL, R2: 14.8 mL
- Manufacturer number 07251254190
Check that your laboratory uses cobas e Immunoassay Analyzers before ordering.
More Information
| Unit Of Measure | Pack |
|---|---|
| Country Of Origin | Unknown |
| Buy American Act (BAA) Compliant | No |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116007 |
| Product Notice |
Returns may require restocking fee License Required |
| Manufacturer Name | Roche Diagnostic Systems |
| Manufacturer Number | 07251254190 |
| Application | Immunoassay Reagent |
| Brand Or Series | cobas® |
| Qty Per Unit of Measure | 1 |
| Container Type | Pack |
| For Use With | For cobas e Immunoassay Analyzers |
| Volume | M: 12.4 mL, R1: 21 mL, R2: 14.8 mL |
| Number Of Tests | 300 Tests |
| Sample Type | Whole Blood Sample |